MAPK1 and leukemia: To gain further insight into the transcriptional effect on downstream MEK/ERK signaling in leukemias with activating mutations, we selectively investigated if expression of FLT3ITD, FLT3N676K, and NRASG12D caused increased expression of known transcriptional output genes and negative feedback regulators of MEK/ERK signaling43.